TICKERNOMICS Sign up
Last Update: 2023-10-04 11:37:49
GELESIS HOLDINGS INC. ( GLS ) https://www.gelesis.com
0.01USD
Sector:
Healthcare
Industry:
Biotechnology
Country:
United States
1y
3y
5y
10y
Historical Returns*:
SPY
14.73%
-98.82%
GLS
SPY
36.71%
-99.86%
GLS
SPY
70.96%
GLS
0.00%
SPY
262.36%
GLS
0.00%
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
0.99
23.92
0.19
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
-0.02
0.05
-0.07
-692.57
0.00
-0.77
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
-683.11
29.44
-394.51
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
4.69
-68.69
-73.82
0.00
Other Earnings and Cash Flow Stats:
GELESIS HOLDINGS INC. ( GLS ) Net Income TTM ($MM) is -38.29
GELESIS HOLDINGS INC. ( GLS ) Operating Income TTM ($MM) is -84.93
GELESIS HOLDINGS INC. ( GLS ) Owners' Earnings Annual ($MM) is 0.00
GELESIS HOLDINGS INC. ( GLS ) Current Price to Owners' Earnings ratio is 0.00
GELESIS HOLDINGS INC. ( GLS ) EBITDA TTM ($MM) is -65.45
GELESIS HOLDINGS INC. ( GLS ) EBITDA Margin is -394.51%
Capital Allocation:
GELESIS HOLDINGS INC. ( GLS ) has paid 0.00 dividends per share and bought back -0.559961 million shares in the past 12 months
GELESIS HOLDINGS INC. ( GLS ) has reduced its debt by 33.031 million USD in the last 12 months
Capital Structure:
GELESIS HOLDINGS INC. ( GLS ) Interest-bearing Debt ($MM) as of last quarter is 26
GELESIS HOLDINGS INC. ( GLS ) Annual Working Capital Investments ($MM) are -37
GELESIS HOLDINGS INC. ( GLS ) Book Value ($MM) as of last quarter is -14
GELESIS HOLDINGS INC. ( GLS ) Debt/Capital as of last quarter is -98%
Other Balance Sheet Stats:
GELESIS HOLDINGS INC. ( GLS ) has 3 million in cash on hand as of last quarter
GELESIS HOLDINGS INC. ( GLS ) has 76 million of liabilities due within 12 months, and long term debt 60 as of last quarter
GELESIS HOLDINGS INC. ( GLS ) has 73 common shares outstanding as of last quarter
GELESIS HOLDINGS INC. ( GLS ) has 0 million USD of preferred stock value
Academic Scores:
GELESIS HOLDINGS INC. ( GLS ) Altman Z-Score is -7.26 as of last quarter
GELESIS HOLDINGS INC. ( GLS ) Piotroski Score is 2.00 as of last quarter
Corporate Governance:
GELESIS HOLDINGS INC. ( GLS ) largest shareholder is Beacon Pointe Advisors, LLC owning 119149 shares at 0.00 ($MM) value
Raju S Kucherlapati(an insider) Bought 92000 shares of GELESIS HOLDINGS INC. ( GLS ) for the amount of $41400.00 on 2022-11-21
52.70% of GELESIS HOLDINGS INC. ( GLS ) is held by insiders, and 29.38% is held by institutions
GELESIS HOLDINGS INC. ( GLS ) went public on 2022-01-13
Other GELESIS HOLDINGS INC. ( GLS ) financial metrics:
FCF:-44.11
Unlevered Free Cash Flow:-57.52
EPS:-0.29
Operating Margin:-683.11
Gross Profit Margin:29.44
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:77.13
Beta:0.00
Buffet's Owners Earnings:0.00
Price to Owner's Earnings:0.00
About GELESIS HOLDINGS INC. ( GLS ) :
Gelesis Holdings, Inc., a commercial stage biotherapeutics company, developing a biomimicry to treat the genesis of obesity and GI-related chronic diseases. It also offers PLENITY, an orally administered, non-stimulant, and non-systemic aid for weight management. In addition, the company develops GS200 for weight loss in prediabetes and type 2 diabetes; and GS500 for functional constipation. Further, it develops pre-clinical product GS300 for non-alcoholic fatty liver disease/non-alcoholic steatohepatitis. Gelesis Holdings, Inc. was incorporated in 2006 and is headquartered in Boston, Massachusetts.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.